Antigen Detection + Antigen Testing of Serious Fungal Infections

MiraVista Diagnostics specializes in antigen detection and antigen testing for serious fungal infections. Since 2002, we have been developing and processing diagnostic mycology tests that consistently produce results to the highest standards in clinical accuracy and sensitivity.

Antigen Test Results You Can Trust

MiraVista Diagnostics currently offers antigen quantitative EIA tests for histoplasma, blastomyces and coccidioides. We also offer aspergillosis antigen galactomannan EIA tests, beta-D-glucan tests and cryptococcus antigen latex agglutination tests. Download a test menu or contact us to learn more about our antigen detection tests.

Company News

Visit MiraVista at ASM Microbe 2018 in Atlanta

MiraVista Diagnostics is exhibiting at ASM Microbe 2018 in Atlanta on June 7-11, 2018. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections. For more information about ASM Microbe…
READ MORE →

MiraVista Receives $630,000 in Federal & State Research Grants

National Institutes of Health (NIH) and the State of Indiana Awarded MiraVista Diagnostics More Than $630,000 in Grant Funding to Support Fungal Disease Research to Develop a New Rapid Detection Test for Coccidioidomycosis MiraVista Diagnostics, LLC (MiraVista), a developer of…
READ MORE →

MiraVista is Participating in the 62nd Annual Cocci Study Group Meeting in Flagstaff, Arizona

MiraVista Diagnostics is participating in the 62nd Annual Cocci Study Group Meeting on April 13-14 in Flagstaff, Arizona. Representatives from the company will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections. To learn more about…
READ MORE →

Inside Indiana Business Life Sciences Features MiraVista Diagnostics

Inside Indiana Business recently featured Indianapolis headquartered MiraVista Diagnostics in its Life Sciences Indiana publication. During the interview, Dr. Lawrence Joseph Wheat shared exciting news about the company’s research initiatives and expansion plans. Read the article below or link directly to…
READ MORE →

MiraVista is Attending the 2018 SCACM Spring Meeting in French Lick, Indiana

MiraVista Diagnostics is attending the South Central Association for Clinical Microbiology’s 2018 SCACM Spring Meeting in French Lick, Indiana on March 7-10, 2018. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →

NIH Approved Institutional Biosafety Committee (IBC) First Meeting Scheduled for January 29

In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….
READ MORE →

LEARN MORE
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo